Interestingly, increasing the clearance of extracellular IGF-II by the treatment with these Man-6-P multivalent molecules inhibited the proliferation of several cancer cell lines due to a decreased IGF1R activation [29]. The gene discussed is IGF1R; the disease is cancer.